Menopause (Xavioer)

studied byStudied by 2 people
5.0(1)
learn
LearnA personalized and smart learning plan
exam
Practice TestTake a test on your terms and definitions
spaced repetition
Spaced RepetitionScientifically backed study method
heart puzzle
Matching GameHow quick can you match all your cards?
flashcards
FlashcardsStudy terms and definitions

1 / 50

encourage image

There's no tags or description

Looks like no one added any tags here yet for you.

51 Terms

1

What is peri-menopause?

The time from which menopause becomes irregular to the Final Menstrual Period

New cards
2

What is menopause?

The cessation of menstrual bleeding for a continuous 12-month period

New cards
3

Smoking, genetics, and body size can affect the ___ of menopause.

age of onset

New cards
4

True or false: Estradiol concentrations increase with aging due to oocyte atresia.

False. Aging leads to atresia (diminished oocytes), which causes decreased estradiol concentrations.

New cards
5

True or False: Aging results in a significant decrease in FSH and LH concentrations.

False. Aging causes a significant increase in FSH and LH concentrations.

New cards
6

What is the effect of the lack of a corpus luteum during menopause?

It leads to a lack of progesterone activity

New cards
7

Testosterone production drops to about ___ of that seen in women in their 20s.

Half

New cards
8

What are vasomotor symptoms of menopause?

Hot flushes and night sweats

New cards
9

Vasomotor symptoms typically last an average of ___ years, with the highest occurrence within ___ years post-menopause.

7; 2

New cards
10

What are some examples of GSM?

  • Urogenital atrophy

  • Vaginal dryness

  • Dyspareunia

  • Recurrent UTIs

  • Urge/stress incontinence

New cards
11

True or False: The STRAW staging system can be used for diagnosing menopause in women with an IUD or hormonal contraceptive use.

False. STRAW staging is not useful if the patient has no uterus, uses hormonal contraceptives, has an IUD, or has had prior procedures affecting menstrual function

New cards
12

What is the most effective option for managing VMS and GSM in menopause?

Menopausal Hormone Therapy (MHT)

New cards
13

The risk of ___, ___, ___, and ___ increases in women who do not meet the criteria for MHT.

heart disease, stroke, VTE, and dementia

New cards
14

What is the primary focus of MHT during the menopause transition?

Alleviation of VMS and GSM

New cards
15

What type of therapy should women with an intact uterus use for MHT? Why?

  • Estrogen + progestogen therapy

  • To prevent unopposed estrogen activity, which can overstimulate the uterine lining and progress to endometrial hyperplasia or cancer

New cards
16

True or false: Estrogen alone is recommended for women with an intact uterus.

False. Estrogen alone can cause overstimulation of the uterine lining, leading to endometrial hyperplasia or cancer

New cards
17

What is the first-line option for reducing the frequency and severity of vasomotor symptoms (VMS)?

Oral estrogen therapy

New cards
18

True or false: Vaginal estrogen formulations are ideal for treating GSM and preventing recurrent UTIs.

True

New cards
19

Vaginal estrogen products minimize ___ absorption while providing adequate relief for GSM.

Systemic

New cards
20

True or false: Systemic estrogen therapy can help improve urinary stress incontinence.

False. Systemic agents may worsen urinary stress incontinence

New cards
21

True or false: Estradiol is bioidentical and the most common form of estrogen therapy.

True

New cards
22

What are CEEs, and how do they differ from estradiol?

CEEs (conjugated equine estrogens) are mixtures, not bioidentical, but are better studied than estradiol

New cards
23

Oral estrogens are affected by ___ and ___ metabolism, which may increase the risk of VTE.

gut; liver

New cards
24

How can oral estrogens impact lipid profiles?

They lower LDL, increase HDL, but may also increase triglycerides

New cards
25

What is a key advantage of transdermal estrogens compared to oral estrogens?

First-pass gut/liver metabolism is avoided, leading to decreased VTE risk and less negative impact on triglycerides

New cards
26

True or False: Transdermal estrogens have a higher risk of VTE compared to oral estrogens.

False. Transdermal estrogens have a decreased VTE risk due to avoiding first-pass gut/liver metabolism

New cards
27

What is a key consideration when using vaginal estrogens?

No systemic progestogen is needed with typical doses because there is little systemic absorption of estrogen (except with the ring, where the dose is higher)

New cards
28

True or False: Vaginal estrogen use at typical doses carries a known risk of systemic absorption.

False. Vaginal estrogens typically have no systemic absorption, so no systemic progestogen is needed

New cards
29

What is the role of progestogens in menopausal hormone therapy?

They protect against endometrial hyperplasia and cancer risk related to unopposed estrogen

New cards
30

True or false: Drospirenone has anti-aldosterone activity and a risk of hyperkalemia.

True

New cards
31

True or False: Micronized progesterone is manufactured in sunflower oil.

False. Micronized progesterone is manufactured in peanut oil (make sure to check patient’s allergies)

New cards
32

Who are progestogens ideal for in menopausal hormone therapy?

Those with contraceptive needs or those who do not tolerate oral or transdermal options

New cards
33

What is ospemifene (Osphena®), and what is it approved for?

Ospemifene is a selective estrogen receptor modulator (SERM) approved for dyspareunia and vaginal dryness/atrophy

New cards
34

True or False: Ospemifene (Osphena®) requires progestogen therapy.

False. Ospemifene does not require progestogen therapy because it has selective tissue activity

New cards
35

When might intravaginal DHEA be considered in menopause therapy?

When non-estrogen therapy is needed

New cards
36

What is the purpose of Tissue-selective Estrogen Complex (TSEC) + Estrogen Agonist Antagonist (EAA, aka SERM)?

It is ideal for those who cannot tolerate progestogen therapy but need to oppose estrogen effects to protect the endometrium

New cards
37

What combination is used in Duavee®?

Conjugated equine estrogens (CEE) + bazedoxifene (a SERM)

New cards
38

What is the role of testosterone in menopausal therapy?

It is of interest for low libido management or sexual dysfunction, though it has no FDA approval and unclear dosing for use

New cards
39

How is the risk of endometrial cancer minimized in menopausal hormone therapy (MHT)?

By using a combination of estrogen and progestogen therapy

New cards
40

True or False: Progestogens can be used either continuously or cyclically, with cyclic therapy preferred if 12 months of amenorrhea have not occurred

True

New cards
41

When is estrogen therapy alone appropriate in menopausal hormone therapy?

In women without a uterus

New cards
42

What are contraindications to menopausal hormone therapy (MHT)?

Undiagnosed vaginal bleeding, treatment of hormone-dependent malignancy, history of estrogen-dependent malignancy, MI, stroke, VTE, dementia, and severe liver disease

New cards
43

What benefits does MHT have on bone health?

It reduces bone turnover, increases bone mineral density (BMD), and decreases hip fracture rates

New cards
44

How should menopausal hormone therapy (MHT) be used to minimize risks?

Limit use/duration and use the lowest doses possible to manage symptoms

New cards
45

True or False: Improvement in vasomotor symptoms (VMS) is typically seen 8-12 weeks after initiating MHT.

True. Full impact assessment may take 8-12 weeks

New cards
46

How often should follow-up occur after initiating MHT?

Follow-up should be every 1-2 months, with an annual evaluation strongly encouraged

New cards
47

Which classes of drugs are effective alternatives for reducing hot flushes and improving mood disorders in menopause?

SSRI/SNRI

New cards
48

True or False: Paroxetine can be used safely with tamoxifen.

False. Paroxetine should be avoided with tamoxifen due to a DDI that inhibits the conversion of tamoxifen to its active metabolite (CYP2D6 inhibition)

New cards
49

What is the role of gabapentin and pregabalin in menopause management?

They have some efficacy in reducing vasomotor symptoms (VMS) based on small studies

New cards
50

How does clonidine work in menopause management?

Clonidine elevates the "flush threshold" and can reduce symptoms, but it is less effective than other options like SSRIs/SNRIs

New cards
51

True or False: Menopausal hormone therapy (MHT) is effective for pregnancy prevention.

False. MHT alone is not effective for pregnancy prevention

New cards
robot